Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
From the bench to Hutch services: Refining gene-editing methods for HSPCs used in pre-clinical applications
From the Paddison lab, Human Biology Division
Searching beyond the streetlight to uncover functional protein domains
From the Paddison Lab, Human Biology Division
Can a tumor that acts like a microbe help us develop better cancer therapies?
Understanding the genetics underlying spontaneous regression of an infectious tumor in Tasmanian devils could point us toward new treatment targets
Scientists discover new process shaping red blood cell development
Finding could shed new light on causes of certain cancers, anemias
Good News: Dr. Cyrus Ghajar receives $1M from Keck Foundation to study why cancer doesn’t spread to skeletal muscle
Celebrating faculty and staff achievements
New potential treatment target for small-cell lung cancer identified
Mouse study identifies gene that promotes tumor development, shows potential of drug inhibitor to slow cancer progression
Good News at Fred Hutch
Celebrating faculty and staff achievements
Galloway, Paddison, Eisenman land Provocative Questions grants
Fred Hutch investigators among first in nation to receive new National Cancer Institute awards to pursue novel, creative directions in cancer research
Four MCB students earn National Science Foundation fellowships
Three-year predoctoral research awards for Spragg, Cech, Hildebrand and Gonzalez
Paddison funded for brain cancer research
Award targets need for glioblastoma therapies, disease model
Paddison joins illustrious list of Pew Scholars
Human Biology Division's Patrick Paddison is among select group of early career scientists to receive Pew Charitable Trusts' $240,000 award